Commentary
While COVID-19 vaccine critics are busy celebrating the fall of Pfizer’s share price and its legal troubles in the United States, the German company BioNTech, the actual legal manufacturer of the so-called “Pfizer vaccine” and the main financial beneficiary of its sales, is continuing its expansion with the full and open support of Germany and the EU. On Monday, Dec. 18, EU Commission President Ursula von der Leyen, German Foreign Minister Annalena Baerbock, Rwandan President Paul Kagame, and BioNTech co-founders Ugur Sahin and Özlem Türeci gathered in the Rwandan capital of Kigali to celebrate the inauguration of BioNTech’s new African mRNA vaccine manufacturing site.
